Today’s papers are reporting a ‘potential breakthrough’ in treating all neurodegenerative disorders. Surely this sounds too good to be true? Let’s look in a bit more detail at the concept behind this research… What do neurodegenerative diseases have in common? The term ‘neurodegenerative disease’ covers a whole span of conditions, all resulting in the loss of nerve […]
Getting out from behind my desk to go and talk first hand about Alzheimer’s Research UK is a privilege I enjoy as part of my job, but the most amazing part is the people I meet through our work. One Saturday in the summer, I drove through the picturesque countryside near Bedford to the small […]
Back in 2002, the news broke that Elan had halted its phase II clinical trial for the AN1792 vaccine, designed to combat Alzheimer’s. It was a severe disappointment for people with Alzheimer’s and their loved ones. Many hopes had been pinned on the vaccine, and its failure saw those hopes dashed for hundreds of thousands […]
Today is World Alzheimer’s Day. No doubt the day will mean something different to everyone touched by Alzheimer’s or another form of dementia. For some, it’s an opportunity to think about those we know affected by dementia, or those who are no longer here. For others, a chance to raise awareness or think about how […]
Alzheimer’s Research UK’s most recent study of dementia prevalence estimated around 820,000 people in the UK to be living with dementia, with that figure expected to rise dramatically. But researchers at the University of Cambridge have been re-evaluating these estimates, revealing intriguing and potentially important changes in dementia rates over the last few decades. Dr […]
What is posterior cortical atrophy? Posterior cortical atrophy (PCA) is a rare condition most often caused by Alzheimer’s disease but surprisingly, despite often having the same underlying disease, people with PCA have a striking difficulty in seeing what and where things are, while their memory for recent events can still be very good. The visual […]
This month we’ll be at the political party conferences urging all parties to continue to back dementia research. With no new drugs since 2003, and those in existence only showing modest efficacy, we desperately need new treatments that can delay the onset, slow the progression and manage the symptoms of dementia. Only through research can we make progress and offer hope to people with dementia.
Alzheimer’s disease is mostly thought of as a memory problem. But as many who deal with the disease know, this isn’t the only problem people experience. Many patients come into clinic reporting difficulty following conversations in busy rooms, or hearing someone over a busy phone line. We’re trying to find out why people with Alzheimer’s have these problems, and what this can tell us about Alzheimer’s disease as a whole.